3-37471057-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002207.3(ITGA9):āc.236A>Cā(p.Lys79Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002207.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGA9 | NM_002207.3 | c.236A>C | p.Lys79Thr | missense_variant | 2/28 | ENST00000264741.10 | NP_002198.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGA9 | ENST00000264741.10 | c.236A>C | p.Lys79Thr | missense_variant | 2/28 | 1 | NM_002207.3 | ENSP00000264741.5 | ||
ITGA9 | ENST00000422441.5 | c.236A>C | p.Lys79Thr | missense_variant | 2/16 | 1 | ENSP00000397258.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251472Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135912
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461806Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727204
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.236A>C (p.K79T) alteration is located in exon 2 (coding exon 2) of the ITGA9 gene. This alteration results from a A to C substitution at nucleotide position 236, causing the lysine (K) at amino acid position 79 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at